| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Surgery,* Institute of Anatomy, Institute of Pathology, University of Leipzig, Leipzig, Germany; the Institute of Pathology, University of Magdeburg, Magdeburg, Germany; and the Laboratory for Experimental Immunology,¶ Academic Medical Center, University of Amsterdam, The Netherlands
The expression of CD97, a member of the EGF-TM7 family with adhesive properties, is proportional to the aggressiveness and lymph node involvement in thyroid tumors. CD97 has never been systematically investigated in other tumors. First, we examined colorectal carcinoma cell lines (n = 18) for CD97 expression and regulation. All cell lines were CD97-positive. The level of CD97 in each line correlated with migration and invasion in vitro. This result was confirmed in CD97-inducible Tet-off HT1080 cells. Transforming growth factor-ß, which inhibits proliferation in transforming growth factor-ß-sensitive LS513 and LS1034 cells, down-regulated CD97 in these cell lines. Examining CD97 during sodium butyrate-induced cell differentiation of Caco-2 cells, we could demonstrate a CD97-decreasing effect. Second, we screened 81 colorectal adenocarcinomas by immunohistology for expression of CD97. Normal colorectal epithelium is CD97-negative. Seventy-five of 81 of the carcinomas expressed CD97. The strongest staining for CD97 occurred in scattered tumor cells at the invasion front compared to cells located within solid tumor formations of the same tumor. Carcinomas with more strongly CD97-stained scattered tumor cells showed a poorer clinical stage as well as increased lymph vessel invasion compared to cases with uniform CD97 staining. In summary, CD97 expression correlates with dedifferentiation, migration, and invasion in colorectal tumor cell lines. Moreover, more strongly CD97-stained tumor cells at the invasion front of colorectal carcinomas indicate the involvement of the molecule in tumor migration and invasion.
This article has been cited by other articles:
 |
|
 |
|
  H. Veninga, S. Becker, R. M. Hoek, M. Wobus, E. Wandel, J. van der Kaa, M. van der Valk, A. F. de Vos, H. Haase, B. Owens, et al. Analysis of CD97 Expression and Manipulation: Antibody Treatment but Not Gene Targeting Curtails Granulocyte Migration J. Immunol., November 1, 2008; 181(9): 6574 - 6583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. van Pel, H. Hagoort, J. Hamann, and W. E. Fibbe CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells Haematologica, August 1, 2008; 93(8): 1137 - 1144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. M. Abbott, I. Spendlove, P. Roversi, H. Fitzgibbon, V. Knott, P. Teriete, J. M. McDonnell, P. A. Handford, and S. M. Lea Structural and Functional Characterization of a Novel T Cell Receptor Co-regulatory Protein Complex, CD97-CD55 J. Biol. Chem., July 27, 2007; 282(30): 22023 - 22032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Galle, D. Sittig, I. Hanisch, M. Wobus, E. Wandel, M. Loeffler, and G. Aust Individual Cell-Based Models of Tumor-Environment Interactions: Multiple Effects of CD97 on Tumor Invasion Am. J. Pathol., November 1, 2006; 169(5): 1802 - 1811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Capasso, L. G. Durrant, M. Stacey, S. Gordon, J. Ramage, and I. Spendlove Costimulation via CD55 on Human CD4+ T Cells Mediated by CD97 J. Immunol., July 15, 2006; 177(2): 1070 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yokoi, P. H. Thaker, S. Yazici, R. R. Rebhun, D.-H. Nam, J. He, S.-J. Kim, J. L. Abbruzzese, S. R. Hamilton, and I. J. Fidler Dual Inhibition of Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor Phosphorylation by AEE788 Reduces Growth and Metastasis of Human Colon Carcinoma in an Orthotopic Nude Mouse Model Cancer Res., May 1, 2005; 65(9): 3716 - 3725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wang, Y. Ward, L. Tian, R. Lake, L. Guedez, W. G. Stetler-Stevenson, and K. Kelly CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells Blood, April 1, 2005; 105(7): 2836 - 2844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Mustafa, A. Eckert, T. Klonisch, A. Kehlen, P. Maurer, M. Klintschar, M. Erhuma, R. Zschoyan, O. Gimm, H. Dralle, et al. Expression of the Epidermal Growth Factor Seven-Transmembrane Member CD97 Correlates with Grading and Staging in Human Oral Squamous Cell Carcinomas Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 108 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Kwakkenbos, W. Pouwels, M. Matmati, M. Stacey, H.-H. Lin, S. Gordon, R. A. W. van Lier, and J. Hamann Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells J. Leukoc. Biol., January 1, 2005; 77(1): 112 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hoffmann, L. C. Hofbauer, V. Scharrenbach, A. Wunderlich, I. Hassan, S. Lingelbach, and A. Zielke Thyrotropin (TSH)-Induced Production of Vascular Endothelial Growth Factor in Thyroid Cancer Cells in Vitro: Evaluation of TSH Signal Transduction and of Angiogenesis-Stimulating Growth Factors J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6139 - 6145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Leemans, A. A. te Velde, S. Florquin, R. J. Bennink, K. de Bruin, R. A. W. van Lier, T. van der Poll, and J. Hamann The Epidermal Growth Factor-Seven Transmembrane (EGF-TM7) Receptor CD97 Is Required for Neutrophil Migration and Host Defense J. Immunol., January 15, 2004; 172(2): 1125 - 1131. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
